#4624 on the rich list of 14,644 insiders
George L. Sing
Director at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
$23.4M
in disclosed stock, −$561K (−2.35%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4624th of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Nov 17, 2026
What the $23.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 23,147 | $923.34 | $21.4M | 91.5% | Form 4, Nov 17, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Trust for Son | 1,000 | $923.34 | $923K | 4.0% | Form 4, Nov 16, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Spouse | 750 | $923.34 | $693K | 3.0% | Form 4, Nov 16, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through Spouse/Cust Son | 400 | $923.34 | $369K | 1.6% | Form 4, Nov 16, 2026 |
Share counts are the amounts George L. Sing reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Sold | REGN | 176 | $956.96 | $168K | View |
| Nov 17, 2026 | Sold | REGN | 359 | $957.49 | $344K | View |
| Nov 17, 2026 | Sold | REGN | 465 | $958.11 | $446K | View |
| Nov 16, 2026 | Sold | REGN | 1,000 | $960.26 | $960K | View |
| Nov 2, 2026 | Sold | REGN | 1,224 | $960.57 | $1.2M | View |
| Nov 2, 2026 | Sold | REGN | 540 | $961.85 | $519K | View |
| Nov 2, 2026 | Sold | REGN | 2,522 | $962.61 | $2.4M | View |
| Nov 2, 2026 | Sold | REGN | 4,338 | $963.47 | $4.2M | View |
| Nov 2, 2026 | Sold | REGN | 2,670 | $964.57 | $2.6M | View |
| Nov 2, 2026 | Sold | REGN | 7,073 | $965.38 | $6.8M | View |
| Nov 2, 2026 | Sold | REGN | 1,522 | $966.27 | $1.5M | View |
| Nov 2, 2026 | Sold | REGN | 1,040 | $967.07 | $1.0M | View |
| Nov 2, 2026 | Sold | REGN | 200 | $970.18 | $194K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4621 | Jerry J. Baack CEO, Bridgewater Bancshares. St. Louis Park, MN | $23.4M |
| 4622 | Russell D. Miller Sr. Executive Vice President, Costco Wholesale. Issaquah, WA | $23.4M |
| 4623 | John C. Huffard, Jr Director, Tenable Holdings. Atlanta, GA | $23.4M |
| 4624 | George L. Sing Director, Regeneron Pharmaceuticals. Tarrytown, NY | $23.4M |
| 4625 | Alan Baratz President & CEO, D-Wave Quantum. Palo Alto, CA | $23.4M |
| 4626 | Brian Goldsmith Chief Operating Officer, Lionsgate Studios. Santa Monica, CA | $23.4M |
| 4627 | Robert Rango Director, KLA. Santa Rosa, CA | $23.4M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$855MBd. Co-Chair, President & CSO. #312 overall
- P. Roy Vagelos$431MDirector. #529 overall
- Neil E. Stahl$54.7MEVP Research and Development. #2374 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Joseph LaRosa$44.4MEVP General Counsel and Secret. #2766 overall
Questions
How much stock does George L. Sing own?
George L. Sing holds $23,357,732 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 4624th on the Stock Rich List.
Is this George L. Sing's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did George L. Sing last buy or sell stock?
The most recent open-market trade on file is a sale of 176 REGN shares on Nov 17, 2026 at $956.96.